Journals / Bozok Tıp Dergisi / 2026 / Cilt: 16 Sayı: 2

EVALUATION OF BRAIN-DERIVED NEUROTROPHIC FACTOR LEVELS IN PATIENTS WITH NASAL SEPTUM DEVIATION AND TURBINATE HYPERTROPHY

Beyin Türevli Nörotrofik Faktör (BDNF) Seviyelerinin Nazal Septum Deviasyonu ve Konka Hipertrofisi Tanılı Hastalarda İncelenmesi

Pages
329–335
Publication Date
2026-06-15
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This study is important as it represents the first investigation in the literature examining BDNF levels in this specific patient population.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Nasal obstruction is a common health problem in the general population.
📊
Key Findings & Data:Material and Methods: A total of 44 patients and 44 controls, aged between 18 and 55 years and without systemic diseases, who presented to the otorhinolaryngology outpatient clinic, were included in the study.
💡
Conclusion & Impact:This study is important as it represents the first investigation in the literature examining BDNF levels in this specific patient population.
🔬Design:Araştırma Makalesi
📍Scope:Comprehensive Sample
⚙️Variables:Beyin Türevli Nörotrofik Faktör · Nazal Septum Deviasyonu · Konka Hipertrofisi

Abstract

Objective: Nasal obstruction is a common health problem in the general population. Its most frequent causes are nasal septal deviation (NSD) and turbinate hypertrophy (TH), which may lead to chronic hypoxia. The aim of this study was to determine serum brain-derived neurotrophic factor (BDNF) levels in patients diagnosed with NSD and TH and to investigate the effect of chronic hypoxia on BDNF. Material and Methods: A total of 44 patients and 44 controls, aged between 18 and 55 years and without systemic diseases, who presented to the otorhinolaryngology outpatient clinic, were included in the study. Blood samples obtained from the participants were centrifuged, and serum BDNF levels were analyzed using the enzyme-linked immunosorbent assay (ELISA) method. Statistical analyses were performed using SPSS version 23.0. Data distribution was assessed using the Shapiro-Wilk test. Normally distributed variables (serum BDNF levels) were analyzed using the independent samples t-test, whereas non-normally distributed variables (age) were analyzed using the Mann-Whitney U test. Results: Serum BDNF levels in the patient group (106.07±9.99 ng/mL) were found to be statistically significantly lower than those in the control group (114.62±8.42 ng/mL) (p:0.00004). BDNF levels did not show a significant correlation with participants' age or sex (p>0.05). Conclusion: Hypoxia resulting from NSD and TH adversely affects serum BDNF levels. Considering the roles of BDNF in neuronal survival and plasticity, individuals with nasal obstruction may be at risk for cognitive functional impairment. This study is important as it represents the first investigation in the literature examining BDNF levels in this specific patient population.

Özet

Amaç: Burun tıkanıklığı, toplumda yaygın görülen sağlık problemidir. En sık nedenleri nazal septum deviasyonu (NSD) ve konka hipertrofisi (KH)’dir ve sonucunda kronik hipoksi görülür. Çalışmanın amacı, NSD ve KH tanılı hastalarda serum beyin türevli nörotrofik faktör (BDNF) düzeylerini belirlemek ve kronik hipoksinin, BDNF üzerindeki etkisini araştırmaktır. Gereç ve Yöntemler: KBB polikliniğine başvuran, 18-55 yaş aralığında, sistemik hastalığı olmayan 44 hasta ve 44 kontrol grubu çalışmaya dahil edildi. Katılımcılardan alınan artık kan örnekleri santrifüj sonrası elde edilen serumlarda BDNF düzeyleri ELISA yöntemi ile analiz edildi. İstatistiksel değerlendirmeler SPSS 23.0 programı kullanılarak yapıldı. Veri dağılımı Shapiro-Wilk testi ile değerlendirildi; normal dağılım gösteren değişkenler (BDNF düzeyleri) bağımsız örneklem t-testi, normal dağılım göstermeyen değişkenler (yaş) ise Mann-Whitney U testi ile analiz edildi. Bulgular: Hasta grubunun serum BDNF düzeyleri (106,07±9,99 ng/ml), kontrol grubunun değerlerinden (114,62±8,42 ng/ml) istatistiksel olarak anlamlı derecede düşük saptandı (p:0.0004). Ayrıca, BDNF düzeylerinin katılımcıların yaşı veya cinsiyeti ile anlamlı bir korelasyon göstermediği belirlendi (p>0,05). Sonuç: NSD ve KH’ye bağlı gelişen hipoksinin serum BDNF düzeylerini olumsuz etkilediğini göstermektedir. BDNF’nin nöronal sağkalım ve plastiklik üzerindeki rolleri göz önüne alındığında, burun tıkanıklığı olan bireylerin bilişsel fonksiyon kayıpları açısından risk altında olabileceği değerlendirilmektedir. Bu çalışma, literatürde bu spesifik hasta grubunda BDNF düzeylerini inceleyen ilk araştırma olması bakımından önemlidir.

🔖

Cite This Article

Keleş, R., Göçmen, A. Y., Dağıstan, H. (2026). EVALUATION OF BRAIN-DERIVED NEUROTROPHIC FACTOR LEVELS IN PATIENTS WITH NASAL SEPTUM DEVIATION AND TURBINATE HYPERTROPHY. Bozok Tıp Dergisi, Cilt: 16 Sayı: 2, 329–335. https://doi.org/10.16919/bozoktip.1922691

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (27)

  1. Akınoğlu B, Mutlu M, Külünkoğlu BA, Kocahan T. Nazal septal deviasyonun kişilerin fiziksel uygunluk seviyesi üzerine etkisi: Pilot çalışma. Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi. 2018;51(2):84-9.
  2. Xie H, Leung KL, Chen L, Chan YS, Ng CP, Fok TF, et al. Brain-derived neurotrophic factor rescues and prevents chronic intermittent hypoxia-induced impairment of hippocampal long-term synaptic plasticity. Neuroscience. 2010;166(1):155-62.
  3. Başaran K, Erdem SS, Aydoğan A. Solunumsal uzun süreli fasilitasyonun sinyal mekanizmaları. Erciyes Üniversitesi Tıp Fakültesi Dergisi. 2015;24(1):70-8.
  4. Akbulut A, Demirel O. Nazal septum deviasyonu ve konka bulloza ilişkisi. ODMFR 2019 Kongre Kitapçığı Özel Sayısı. 2019:31-6.
  5. Özkırış M, Mutlu C. Kulak burun boğaz polikliniğine başvuran hastaların nazal septum deviasyonu sıklığı. Kayseri Tıp Dergisi. 2010;2(2):72-6.
  6. Grymer LF, Melsen B. The morphology of the nasal septum in identical twins. Laryngoscope. 1989;99(6):642-6.
  7. Bhattacharyya N. Symptom and disease severity differences between nasal septal deviation and chronic rhinosinusitis. Otolaryngol Head Neck Surg. 2005;133(2):173-7.
  8. Min YG, Jung HW, Kim CS. Measurements of cross-sectional area of the nasal cavity by acoustic rhinometry and CT scanning. Laryngoscope. 1995;105(7):757-9.
  9. Zielnik-Jurkiewicz B, Olszewska-Sosińska O. The nasal septum deformities in children and adolescents from Warsaw, Poland. Int J Pediatr Otorhinolaryngol. 2006;70(4):731-6.
  10. Özçimen A, Yaldız G. Bireysel ses eğitimi dersi 1. sınıf öğrencilerinin akustik rinometri ve ses analizi verilerinin değerlendirilmesi. Selçuk Üniversitesi Sosyal Bilimler Enstitüsü Dergisi. 2013;(29):165-78.
  11. Björkholm C, Monteggia LM. BDNF - a key transducer of antidepressant effects. Neuropharmacology. 2016;102:72-9.
  12. Li Z, Zhang C, Fan J, Yuan C, Huang J, Chen J, et al. Brain-derived neurotrophic factor levels and bipolar disorder in patients in their first depressive episode: 3-year prospective longitudinal study. Br J Psychiatry. 2014;205(1):29-35.
  13. Moosaie F, Mohammadi S, Saghazadeh A, Dehghani Firouzabadi F, Rezaei N. Brain-derived neurotrophic factor in diabetes mellitus: a systematic review and meta-analysis. PLoS One. 2023;18(2):e0268816.
  14. Yorbık O, Cansever A, Söhmen T. Otizmde nörönal görüşler. Çocuk ve Gençlik Ruh Sağlığı Dergisi. 2002;9(2):118-27.
  15. Dagistan H, Turan Y. The effect of septoplasty on endothelial function in patients with marked nasal septal deviation. J Craniofac Surg. 2021;32(7):e673-6.
  16. Rosenblum S, Smith TN, Wang N, Chua JY, Westbroek E, Wang K, et al. Pre-treatment of human embryonic-derived neural progenitor cells with BDNF increases migration of cells to the brain and elicits functional recovery in a mouse model of hypoxic-ischemia. Stroke. 2012;43(Suppl 1):A199.
  17. Ekinci A, Karataş D, Yetiş A, Demir E, Özcan M. Serum Oxidative Stress Levels in Patients with Nasal Septal Deviation. Turk Arch Otorhinolaryngol. 2017;55(3):125-8.
  18. Düzenli U, Bozan N, Çetin Y, Çetin YS, Demir H. Evaluation of the relationship between nasal septum deviation and oxidative stress markers. J Craniofac Surg. 2019;30(3):851-3.
  19. Kaplan GB, Vasterling JJ, Vedak PC. Brain-derived neurotrophic factor in traumatic brain injury, post-traumatic stress disorder and their comorbid conditions: role in pathogenesis and treatment. Behav Pharmacol. 2010;21(5-6):427-37.
  20. Rojas Vega S, Strüder HK, Vera Wahrmann B, Schmidt A, Bloch W, Hollmann W. Acute BDNF and cortisol response to low intensity exercise and following ramp incremental exercise to exhaustion in humans. Brain Res. 2006;1121(1):59-65.
  21. Karaman A, Çakar H, Vurmaz A, Gürsoy F, Koçak S, Serteser M. Ağır egzersizin oksidatif stres üzerindeki etkisi. Kocatepe Tıp Dergisi. 2003;4(1):33-7.
  22. Kwon DH, Kim BS, Chang H, Kim YI, Jo SA, Leem YH. Exercise ameliorates cognition impairment due to restraint stress-induced oxidative insult and reduced BDNF level. Biochem Biophys Res Commun. 2013;434(2):245-51.
  23. Li Y. Ma J. Zhang W.X. Cao YL. Lei C. Serum Brain-derived Neurotrophic Factor Levels as a Biomarker of Treatment Response in Patients With Depression: ystematic Review and Meta-analysis. Actas Esp Psiquiatr. 2025;53(4):857-67.
  24. Sun Y, Shi X, Ohm M, Korte M, Zagrebelsky M. Deciphering genetic causality between plasma brain-derived neurotrophic factor and 91 circulating inflammatory proteins through bidirectional Mendelian randomization. Sci Rep. 2025;15:10312.
  25. Wang G, Zhang H, Sun J, Zhang Y, He F, Zou J. Cyclosporin A impairs neurogenesis and cognitive abilities in brain development via the IFN-γ-Shh-BDNF pathway. Int Immunopharmacol. 2021;96:107744.
  26. Shafiee A, Beiky M, Mohammadi I, Rajai S, Jafarabady K, Moradi S, et al. Effect of smoking on brain-derived neurotrophic factor (BDNF) blood levels: a systematic review and meta-analysis. J Affect Disord.2024;349:525-33.
  27. Wang G, Zhang H, Sun J, Zhang Y, He F, Zou J. Cyclosporin A impairs neurogenesis and cognitive abilities in brain development via the IFN-γ-Shh-BDNF pathway. Int Immunopharmacol. 2021;96:107744.